Tex. Ins. Code § 1369.353

Current with legislation from the 2023 Regular and Special Sessions signed by the Governor as of November 21, 2023.

Section 1369.353 - Criteria for Drugs on Maximum Allowable Cost Lists

A health benefit plan issuer or pharmacy benefit manager may not include a drug on a maximum allowable cost list unless:

(1) the drug:

(A) has an "A" or "B" rating in the most recent version of the United States Food and Drug Administration's Approved Drug Products with Therapeutic Equivalence Evaluations, also known as the Orange Book; or

(B) is rated "NR" or "NA" or has a similar rating by a nationally recognized reference; and

(2) the drug is:

(A) generally available for purchase by pharmacists and pharmacies in this state from a national or regional wholesaler; and

(B) not obsolete.

Tex. Ins. Code § 1369.353

Added by Acts 2015, Texas Acts of the 84th Leg. - Regular Session, ch. 596,Sec. 1, eff. 1/1/2016.